The FDA Refused to Review a Flu Vaccine, Contrary to Evidence. Now the Agency Reversed Itself

On February 3, the Food and Drug Administration’s (FDA’s) Center for Biologics Evaluation and Research (CBER) issued Moderna a refusal-to-file letter for its mRNA influenza vaccine, mRNA-1010.

read more